PCSK9 inhibitor alleviates experimental pulmonary fibrosis-induced pulmonary hypertension via attenuating epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling in vivo and in vitro
BackgroundThe co-occurrence of pulmonary hypertension (PH) in patients with pulmonary fibrosis (PF) is linked to a more unfavorable prognosis and increased mortality compared to PF cases without PH. Early intervention and comprehensive management are pivotal for improving survival outcomes. Proprote...
Hlavní autoři: | Jiancheng Lin, Zetao Pan, Jiayan Sun, Xiaowan Wang, Di Yin, Cunyang Huo, Qiang Guo |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Frontiers Media S.A.
2024-12-01
|
Edice: | Frontiers in Medicine |
Témata: | |
On-line přístup: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1509168/full |
Podobné jednotky
-
Increased serum albumin corrected anion gap levels are associated with poor prognosis in septic patients with liver cirrhosis
Autor: Zetao Pan, a další
Vydáno: (2024-09-01) -
Fatty acid-binding protein 5 aggravates pulmonary artery fibrosis in pulmonary hypertension secondary to left heart disease via activating wnt/β-catenin pathway
Autor: Qian Lei, a další
Vydáno: (2022-09-01) -
PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
Autor: Ding-Qiang Chen, a další
Vydáno: (2024-07-01) -
Knockdown of YAP inhibits growth in Hep-2 laryngeal cancer cells via epithelial-mesenchymal transition and the Wnt/β-catenin pathway
Autor: Xiaomin Tang, a další
Vydáno: (2019-07-01) -
FERMT3 mediates cigarette smoke-induced epithelial–mesenchymal transition through Wnt/β-catenin signaling
Autor: Xiaoshan Su, a další
Vydáno: (2021-11-01)